Ramamurthy Suhaas, Ahuja Priyanka, Dahiya Dushyant Singh, Hayat Umar, Ahuja Neha, Bharadwaj Hareesha Rishab, Gangwani Manesh Kumar, Inamdar Sumant
Department of Medicine, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry 605006, India.
Department of Internal Medicine, University of Toledo, Toledo, OH 43606, USA.
J Clin Med. 2025 Aug 30;14(17):6141. doi: 10.3390/jcm14176141.
Zenker's diverticulum (ZD) is an esophageal condition that results in an outpouching of the mucosal layer through a weakened area in the hypopharyngeal wall. This condition can cause symptoms like dysphagia, regurgitation, and aspiration, impacting patients' quality of life. Historically, open surgery was the primary treatment. Although effective, this method is associated with longer recovery times and risks such as infections, nerve damage, and prolonged hospitalization. Rigid endoscopic stapling emerged as a less invasive alternative, offering high success rates for patients with favorable anatomy. Zenker's peroral endoscopic myotomy (Z-POEM), adapted from treatments for achalasia, represents the latest advancement in ZD management. It involves creating a submucosal tunnel and precisely dividing the cricopharyngeus muscle. Z-POEM is minimally invasive and often provides quick relief with a high success rate of around 92%, while enabling outpatient treatment or brief hospital stays. However, it requires specialized expertise, and long-term data on recurrence rates are still emerging. This review discusses the evolution of these treatment modalities through comprehensive searches of PubMed, MEDLINE, and ScienceDirect databases. Studies reporting on treatment outcomes, complication rates, operative times, and clinical success associated with open surgery, rigid endoscopic stapling, and Z-POEM were included, with emphasis on meta-analyses, multicenter studies, and large case series highlighting Z-POEM's comparable success to open surgery and increased patient tolerance. Open surgery achieves long-term symptom resolution rates of 90-95% but is associated with higher complication rates (up to 30%) and prolonged recovery times. Rigid endoscopic stapling offers symptom relief in approximately 90% of cases, with lower morbidity and shorter hospital stays (1-2 days), though anatomical limitations restrict its use. Z-POEM has demonstrated clinical success rates of 85.5-93%, with major complications reported in 4.8-5% of cases and recurrence rates as low as 1.4% at one-year follow-up in larger diverticula. Z-POEM's minimally invasive nature and suitability for high-risk patients make it increasingly preferred in specialized centers. Management of Zenker's diverticulum has evolved significantly, with endoscopic techniques, particularly Z-POEM, offering comparable success to open surgery but with fewer complications and faster recovery. Ongoing advances in endoscopic equipment and technique, along with emerging data on long-term outcomes, are likely to further refine treatment algorithms for ZD, especially for elderly and high-risk populations. Future directions in ZD management include ongoing research to enhance the safety and efficacy of endoscopic techniques, with new technologies on the horizon that could further improve outcomes and accessibility.
Zenker憩室(ZD)是一种食管疾病,导致黏膜层通过下咽壁的薄弱区域向外突出。这种疾病可引起吞咽困难、反流和误吸等症状,影响患者的生活质量。历史上,开放手术是主要的治疗方法。虽然有效,但这种方法恢复时间较长,且存在感染、神经损伤和住院时间延长等风险。硬质内镜吻合术作为一种侵入性较小的替代方法,对于解剖结构良好的患者成功率较高。借鉴贲门失弛缓症的治疗方法发展而来的经口内镜下肌切开术(Z-POEM)是ZD治疗的最新进展。它包括创建一个黏膜下隧道并精确切断环咽肌。Z-POEM微创,通常能迅速缓解症状,成功率高达92%左右,还能实现门诊治疗或短期住院。然而,它需要专业技能,复发率的长期数据仍在不断涌现。本综述通过全面检索PubMed、MEDLINE和ScienceDirect数据库,探讨了这些治疗方式的演变。纳入了报告开放手术、硬质内镜吻合术和Z-POEM的治疗结果、并发症发生率、手术时间和临床成功率的研究,重点是荟萃分析、多中心研究和大型病例系列,突出了Z-POEM与开放手术相当的成功率和更高的患者耐受性。开放手术的长期症状缓解率为90%-95%,但并发症发生率较高(高达30%),恢复时间较长。硬质内镜吻合术在约90%的病例中可缓解症状,发病率较低,住院时间较短(1-2天),不过解剖学限制限制了其应用。Z-POEM的临床成功率为85.5%-93%,4.8%-5%的病例报告有严重并发症,较大憩室在一年随访时复发率低至1.4%。Z-POEM的微创性质和对高危患者的适用性使其在专科中心越来越受青睐。Zenker憩室的治疗有了显著进展,内镜技术,尤其是Z-POEM,与开放手术成功率相当,但并发症更少,恢复更快。内镜设备和技术的不断进步,以及长期结局的新数据,可能会进一步优化ZD的治疗方案,特别是针对老年和高危人群。ZD治疗的未来方向包括持续研究以提高内镜技术的安全性和有效性,即将出现的新技术可能会进一步改善治疗效果和可及性。